MedPath

Magnesium

Generic Name
Magnesium
Brand Names
Vitafol-one
Drug Type
Small Molecule
Chemical Formula
H2Mg
CAS Number
7439-95-4
Unique Ingredient Identifier
I38ZP9992A

Overview

Magnesium is classified as an alkaline earth metal and has 2 hydration shells. The element can be found in abundance in the hydrosphere and in mineral salts such as dolomite and magnesium carbonate. Common dietary sources of magnesium include nuts (cashews, peanuts, almonds), beans, bananas, apples, carrots, broccoli, and leafy greens. Magnesium is an important enzyme cofactor and is essential to several metabolic processes. Further, the mineral helps regulate blood pressure and is necessary for RNA, DNA and protein synthesis among several other functions. Despite the importance of magnesium and its availability via several food sources, an estimated 56 to 68% of adults who live in developed, western countries do not meet the recommended daily intake (RDI) of magnesium. Several factors and common behaviours reduce the availability of magnesium in the diet such as food processing and cooking vegetables (which are normally a rich source of magnesium).

Indication

Healthy levels of magnesium can be achieved through a well balanced diet, but if food sources are insufficient, magnesium supplements can be used to prevent and treat magnesium deficiencies. In medicine, various magnesium salts may be used in laxative and antacid products. For example, magnesium citrate is available over-the-counter and may be used to manage occasional constipation. Magnesium sulfate may be used on its own or with total parenteral nutrition to treat hypomagnesemia. Magnesium sulfate is also indicated to prevent seizures in pregnant women with pre-eclampsia, and to manage seizures associated with eclampsia.

Associated Conditions

  • Calcium Deficiency
  • Magnesium Deficiency
  • Zinc Deficiency

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/01
Phase 3
Not yet recruiting
2024/12/30
Phase 4
Not yet recruiting
2024/12/20
Phase 4
Not yet recruiting
2024/12/06
Phase 2
Not yet recruiting
2024/11/26
Phase 3
Recruiting
BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.
2024/11/22
Phase 2
Recruiting
2024/11/12
Phase 4
Not yet recruiting
2024/11/07
Phase 4
Not yet recruiting
2024/10/04
Phase 3
Completed
Muhammad Aamir Latif
2024/09/19
Phase 2
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Nutritional Specialties, Inc.
83027-0036
ORAL
15 [hp_X] in 1 mL
4/14/2025
Centurion Labs, LLC
23359-105
ORAL
30 mg in 1 1
1/22/2024
Acella Pharmaceuticals, LLC
42192-321
ORAL
45 mg in 1 1
1/5/2018
Everett Laboratories, Inc.
0642-0092
ORAL
5 mg in 1 1
4/18/2012
Everett Laboratories, Inc.
0642-0070
ORAL
20 mg in 1 1
9/1/2021
Pharmics, Inc.
0813-0202
ORAL
100 mg in 1 1
9/6/2012
Exeltis USA, Inc.
0642-0079
ORAL
25 mg in 1 1
12/31/2022
Deseret Biologicals, Inc.
43742-1312
ORAL
8 [hp_X] in 1 mL
5/27/2025
Dr. Donna Restivo DC
62185-0062
ORAL
8 [hp_X] in 1 mL
5/23/2025
Sterling-Knight Pharmaceuticals, LLC
69336-352
ORAL
15 mg in 1 1
3/9/2020

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.